Rafferty Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $74.9K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $58.5K | Buy |
|
|||||
|
2024
Q4 | $81.5K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $21.1K | Buy |
|
|||||
|
2022
Q4 | $67.9K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $172K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $2.09M | Sell |
|
|||||
|
2021
Q1 | $3.08M | Buy |
|
|||||
|
2020
Q4 | $776K | Sell |
|
|||||
|
2020
Q3 | $1.95M | Buy |
|
|||||
|
2020
Q2 | $1.13M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.87M | Sell |
|
|||||
|
2019
Q3 | $3.46M | Buy |
|
|||||
|
2019
Q2 | $4.34M | Buy |
|
|||||
|
2019
Q1 | $2.76M | Buy |
|